Genocea Biosciences, Inc. filed a first amended disclosure statement in the US Bankruptcy Court on March 21, 2023. The amended disclosure statement filed is related to the amended plan of reorganization filed by the debtor on February 9, 2022. As per the first amended disclosure statement filed there is no material change described.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -99.00% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 58 | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- GNCAQ Stock
- News Genocea Biosciences, Inc.
- First Amended Disclosure Statement Filed by Genocea Biosciences, Inc.